7 results
-
List item
National expert: Kaisa Mari Hämäläinen, Finnish Medicines Agency (updated)
- Declaration of interests - 39.42 KB | PDF
- Curriculum Vitae - 32.19 KB | PDF
development of asthma drugs, Easyhaler, writing protocols, reports … of budesonide inhaler from Easyhaler® and from Turbuhaler® in … dipropionate inhaled via Easyhaler or via Diskhaler in healthy … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,27-30 May 2008
CHMP, Last updated: 02/06/2008as amended for Salbutamol Easyhaler “Orion” inhalation powder … as amended for Salbutamol Easyhaler “Orion” inhalation powder … -
List item
Human medicine European public assessment report (EPAR): BiResp Spiromax (updated)
Budesonide, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive; Asthma
Date of authorisation: 28/04/2014, Revision: 12, Authorised, Last updated: 15/05/2023 -
List item
Human medicine European public assessment report (EPAR): DuoResp Spiromax (updated)
Budesonide, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive; Asthma
Date of authorisation: 28/04/2014, Revision: 12, Authorised, Last updated: 11/05/2023 -
List item
Referral: Inhaled corticosteroids containing medicinal products indicated in the treatment of chronic obstructive pulmonary disease
beclometasone, budesonide, flunisolide, fluticasone propionate, fluticasone furoate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 28/04/2016, EC decision date: 29/06/2016, Last updated: 15/07/2016 -
List item
Public data from Article 57 database
Last updated: 17/10/2022 -
List item
CHMP: meeting archive 2001-2009
Last updated: 18/11/2013